Epimorphic regeneration approach to tissue replacement in adult mammals.

TitleEpimorphic regeneration approach to tissue replacement in adult mammals.
Publication TypeJournal Article
Year of Publication2010
AuthorsAgrawal V, Johnson SA, Reing J, Zhang L, Tottey S, Wang G, Hirschi KK, Braunhut S, Gudas LJ, Badylak SF
JournalProc Natl Acad Sci U S A
Volume107
Issue8
Pagination3351-5
Date Published2010 Feb 23
ISSN1091-6490
KeywordsAmputation, Animals, Biological Factors, Cell Proliferation, Chemotaxis, Extracellular Matrix, Humans, Mice, Mice, Inbred C57BL, Models, Animal, Multipotent Stem Cells, Regeneration, Wound Healing
Abstract

Urodeles and fetal mammals are capable of impressive epimorphic regeneration in a variety of tissues, whereas the typical default response to injury in adult mammals consists of inflammation and scar tissue formation. One component of epimorphic regeneration is the recruitment of resident progenitor and stem cells to a site of injury. Bioactive molecules resulting from degradation of extracellular matrix (ECM) have been shown to recruit a variety of progenitor and stem cells in vitro in adult mammals. The ability to recruit multipotential cells to the site of injury by in vivo administration of chemotactic ECM degradation products in a mammalian model of digit amputation was investigated in the present study. Adult, 6- to 8-week-old C57/BL6 mice were subjected to midsecond phalanx amputation of the third digit of the right hind foot and either treated with chemotactic ECM degradation products or left untreated. At 14 days after amputation, mice treated with ECM degradation products showed an accumulation of heterogeneous cells that expressed markers of multipotency, including Sox2, Sca1, and Rex1 (Zfp42). Cells isolated from the site of amputation were capable of differentiation along neuroectodermal and mesodermal lineages, whereas cells isolated from control mice were capable of differentiation along only mesodermal lineages. The present findings demonstrate the recruitment of endogenous stem cells to a site of injury, and/or their generation/proliferation therein, in response to ECM degradation products.

DOI10.1073/pnas.0905851106
Alternate JournalProc. Natl. Acad. Sci. U.S.A.
PubMed ID19966310
PubMed Central IDPMC2840465
Grant ListF30 HL102990-02 / HL / NHLBI NIH HHS / United States